This page shows the latest rheumatoid arthritis news and features for those working in and with pharma, biotech and healthcare.
The therapy is also already approved in the EU for adults with radiographic axial spondyloarthritis, non-radiographic axial spondyloarthritis, psoriatic arthritis, rheumatoid arthritis and ulcerative colitis, as well as for adults
The recommendation comprises all indications covered by the reference medicine, including Crohn’s disease, plaque psoriasis, ulcerative colitis, rheumatoid arthritis and uveitis.
The recommendation includes multiple indications such as rheumatoid arthritis and Crohn’s disease. ... adalimumab). The recommendation comprises all indications covered by the reference medicine, including Crohn’s disease, plaque psoriasis,
The companies will focus on developing therapies for rheumatoid arthritis and lupus. ... Gilead and EVOQ Therapeutics (EVOQ) have entered into a collaboration and licensing agreement aimed at advancing immunotherapies for the treatment of rheumatoid
Like Actemra, which was approved in 2010 to treat rheumatoid arthritis, Kineret has been on the US market for more than two decades for the treatment of RA, and has been
AbbVie’s Rinvoq (upadacitinib) has been accepted by the Scottish Medicines Consortium (SMC) as a treatment for moderate-to-severe active rheumatoid arthritis (RA).
More from news
Approximately 61 fully matching, plus 470 partially matching documents found.
profile. Biosimilars are used to treat a vast range of conditions, including chronic diseases such as rheumatoid arthritis, as well as certain types of cancers.
These cost restrictions have significant effects: people living with rheumatoid arthritis or psoriatic arthritis saw reduced treatment effectiveness and therapy adherence while on a step therapy programme compared with those without.
By Max Noble. Patients, or should we say people, with conditions such as asthma, rheumatoid arthritis and lupus have never had as much access to medical information as they do today.
Take someone with rheumatoid arthritis. They may be on several medications yet one company will only support through their drug,” said Noble.
and Rheumatoid Arthritis (RA). ... people with moderate as well as severe rheumatoid arthritis – aiming to avoid irreversible damage as early as possible.
More from intelligence
Approximately 0 fully matching, plus 47 partially matching documents found.
He joins the firm from the National Rheumatoid Arthritis Society, where he was its head of government affairs, leading the policy and public affairs functions. ... During his time at the National Rheumatoid Arthritis Society, Hewitt ran UK campaigns to
oncology, rheumatoid arthritis and eye health.
His vast experience in big pharma and his sharp strategic view will help us bring Galapagos to the next level, as we prepare to have our rheumatoid arthritis molecule GLPG0634 enter
In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is
Meanwhile, Vicky joined Liberation last year and in her new role will continue to work across a range of therapeutic areas including men's health, rheumatoid arthritis and eye health.
More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.
For example, new commonalities have been discovered between Type 1 diabetes, lupus, multiple sclerosis and rheumatoid arthritis, suggesting that drugs already in use to treat one autoimmune disease could be equally
In this article, we will examine three key disease areas: COPD, rheumatoid arthritis and multiple sclerosis to determine which drug types have been the winners and losers in terms of usage ... Rheumatoid arthritis. Rheumatoid arthritis has seen a
The other side of … rheumatoid arthritis. “I harassed my GP enough to get it caught early”. ... Meet Georgie. At age 26, Georgie was diagnosed with rheumatoid arthritis, an autoimmune inflammatory condition that affects up to 1% of the population
Lucid Group has been named as a finalist in the PM360 2020 Trailblazer Initiative Awards in the HCP Education category, for the program LiBRA 2019: Looking beyond the joint in rheumatoid ... arthritis (RA): Is there a missing link in RA management?
Its programme – ‘LiBRA 2019: Looking beyond the joint in rheumatoid arthritis (RA): Is there a missing link in RA management?’ – won the category, with a high commendation going to ‘CLEAR HORIZONS – ... We were thrilled that our work in both
More from PMHub
Approximately 8 fully matching, plus 19 partially matching documents found.
No results were found
A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas...